Cargando…
Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1/Th17 immune response
Allergic contact dermatitis (ACD) is a type IV hypersensitivity mainly mediated by Th1/Th17 immune response. Topical corticosteroid is currently the first-line treatment for allergic contact dermatitis (ACD) and systemic administration of immunosuppressive drugs are used in patients with severe diss...
Autores principales: | Wongchang, Thamrong, Pluangnooch, Panwadee, Hongeng, Suradej, Wongkajornsilp, Adisak, Thumkeo, Dean, Soontrapa, Kitipong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148813/ https://www.ncbi.nlm.nih.gov/pubmed/37120440 http://dx.doi.org/10.1038/s41598-023-34211-x |
Ejemplares similares
-
Cytokine-induced killer cells: A novel treatment for allergic airway inflammation
por: Pluangnooch, Panwadee, et al.
Publicado: (2017) -
Immunosuppressive effect of hispidulin in allergic contact dermatitis
por: Thitilertdecha, Premrutai, et al.
Publicado: (2019) -
Curcumin inhibited hepatitis B viral entry through NTCP binding
por: Thongsri, Piyanoot, et al.
Publicado: (2021) -
IL-9 Regulates Allergen-Specific Th1 Responses in Allergic Contact Dermatitis
por: Liu, Juan, et al.
Publicado: (2014) -
Proteomic Profiles of Mesenchymal Stem Cells Induced by a Liver Differentiation Protocol
por: Leelawat, Kawin, et al.
Publicado: (2010)